Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Emmanuele Kouvousis: DOAC Dose Adjustments for Older Patients
Emmanuele Kouvousis/LinkedIn
Mar 31, 2026, 12:50

Emmanuele Kouvousis: DOAC Dose Adjustments for Older Patients

Emmanuele Kouvousis, Non-Invasive Cardiologist, Scientific Director at Affidea, shared a post on LinkedIn:

“DOAC dose adjustments for older patients

In older adults, DOAC dose adjustment is largely driven by renal function, age, and low body weight.

Below is a concise, agent-specific summary based on the provided data.

General principles in older patients

  • Bleeding risk is higher in older people with renal impairment, prompting cautious dosing and regular renal monitoring on DOACs.[1]
  • For all DOACs, creatinine clearance (CrCl), not eGFR, should guide dosing.[1]

Apixaban (nonvalvular AF, renal impairment table)

  • Standard: 5 mg twice daily if CrCl ≥30 mL/min and ABC rule not met.[1]
  • Reduce to 2.5 mg twice daily if ≥2 of: age ≥80 years, body weight ≤60 kg, serum creatinine ≥133 µmol/L (applies across CrCl ≥30).[1]
  • CrCl 15–29 mL/min: 2.5 mg twice daily.[1]
  • CrCl <15: not recommended/contraindicated.[1]

Dabigatran (nonvalvular AF)

  • Usual: 150 mg twice daily.[1]
  • If age ≥80 years or concomitant verapamil: 110 mg twice daily.[1]
  • If age 75–80, CrCl 30–50, GORD, or increase bleeding risk: consider 110 mg twice daily.[1]
  • CrCl <30 mL/min: not recommended/contraindicated.[1]
  • Bleeding and stroke risk both increase with age >75 years.[2]

Edoxaban (nonvalvular AF)

  • Standard: 60 mg once daily for CrCl >50–95 mL/min.[3]
  • 30 mg once daily if CrCl 15–50 mL/min or body weight ≤60 kg or selected P‑gp inhibitors.[3][1]
  • CrCl >95 mL/min: do not use (reduced efficacy vs warfarin).[3]
  • CrCl <15 mL/min: insufficient data/not recommended.[3]

Rivaroxaban (nonvalvular AF)

  • CrCl >50 mL/min: 20 mg once daily with evening meal.[4]
  • CrCl <50 mL/min (≥15): 15 mg once daily.[4][1]
  • CrCl <15 mL/min or dialysis: not recommended.[4]

Monitoring in older adults

  • At least annual renal and liver monitoring, more frequently when CrCl falls into the 30s or 20s (e.g., 3‑monthly, 2‑monthly).[1

References:

  1. Direct Oral Anticoagulant Dosing for Stroke Prevention in People with Nonvalvular Atrial Fibrillation and Renal
  2. Dabigatran (Pradaxa) – Geriatric Dosing and Uses
  3. Edoxaban (Savaysa) – Adult Dosing and Uses
  4. Rivaroxaban (Xarelto) – Adult Dosing and Uses“

Stay updated with Hemostasis Today.

 

AF Apixaban dabigatran Direct Oral Anticoagulant edoxaban Emmanuele Kouvousis Hematology Hemostasis Hemostasis News Hemostasis Today Kevin Fernando Medicine Medscape Reference Rivaroxaban thrombosis
NewsFeed